Skip to main content
SpringerLink
Log in

Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease)

  • Case Report
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder, which confers an increased risk of a wide range of cancers, and malignant tumors are the most common cause of death in individuals with NF1. Although in children with NF1, the most common neoplasms are optic nerve gliomas and brain tumors, an elevated risk of myeloid leukemia and an increased relative risk of acute lymphoblastic leukemia and non-Hodgkin lymphoma were reported. In adults with NF1, the relative risk of brain tumor is 100 times higher than in the general population. Cases of malignant lymphoma occurring in NF1 adult patients have been reported. However, the association between NF1 and lymphoproliferative diseases is still debated. We report a case of CNS primitive lymphoma in an adult patient who resulted positive for NF1 at genetic testing. At present, only one case of CNS lymphoma in an adult patient displaying clinical criteria for NF1 diagnosis has been reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Friedman JM (1999) Epidemiology of neurofibromatosis type 1. Am J Med Genet 89(1):1–6

    Article  PubMed  CAS  Google Scholar 

  2. Zöller ME, Rembeck B, Odén A, Samuelsson M, Angervall L (1997) Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 79(11):2125–2131

    Article  PubMed  Google Scholar 

  3. Sørensen SA, Mulvihill JJ, Nielsen A (1986) Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314(16):1010–1015

    Article  PubMed  Google Scholar 

  4. Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33–40

    Article  PubMed  CAS  Google Scholar 

  5. Niemayer CM, Arico M, Basso G et al (1997) Chronic myelomonocitic leukaemia in childhood: a retrspecitive analysis of 10 cases. European Working Group on Myelodysplastic Sindromes in choldhood (EWONG-MDS). Blood 89:3534–3543

    Google Scholar 

  6. Stiller CA, Chessells JM, Fitchett M (1994) Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 70(5):969–972

    Article  PubMed  CAS  Google Scholar 

  7. Gutmann DH, Rasmussen SA, Wolkstein P, MacCollin MM, Guha A, Inskip PD, North KN, Poyhonen M, Birch PH, Friedman JM (2002) Gliomas presenting after 10 in individuals with neurofibromatosis type 1 (NF1). Neurology 59:759–761

    Google Scholar 

  8. Dohi O, Hatori M, Ichinohasama R, Hosaka M, Hashimoto S, Kokubun S (2006) Diffuse large B-cell lymphoma arising in a patient with neurofibromatosis type I and in a patient with neurofibromatosis type II. Tohoku J Exp Med 208(2):169–176

    Article  PubMed  Google Scholar 

  9. Herbert CR, McBurney EI (2003) Cutaneous T-cell lymphoma in a patient with neurofibromatosis type 1. Cutis. 72(1):27–30

    PubMed  Google Scholar 

  10. Zein G, Yu E, Tawansy K, Berta A, Foster CS (2004) Neurofibromatosis type 1 associated with central nervous system lymphoma. Ophthalmic Genet 25(1):49–51

    Article  PubMed  Google Scholar 

  11. Upadhyaya M, Kluwe L, Spurlock G, Monem B, Majounie E, Mantripragada K, Ruggieri M, Chuzhanova N, Evans DG, Ferner R, Thomas N, Guha A, Mautner V (2008) Germline and somatic NF1 gene mutation spectum in NF1 associated malignant peripheral nerve sheath tumors. Human mutat 29(1):74–82

    Google Scholar 

  12. Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713–1720

    Article  PubMed  CAS  Google Scholar 

  13. Steinemann D, Arning L, Praulich I, Stuhrmann M, Hasle H, Stary J, Schlegelberger B, Niemeyer CM, Flotho C (2010) Mitotic recombination and compound heterozygous mutations are predominat Nf1 inactivation mechanisms in children with Juvenile myelomonocitic leukemia and neurofibromatosis type 1. Haematologica 95:320–323

    Google Scholar 

  14. De Raedt T, Maertens O, Chmara M, Brems H, Heyns I, Sciot R, Majounie E, Upadhyaya M, De Schepper S, Speleman F, Messiaen L, Vermeesch JR, Legius E (2006) Somatic loss. Genes Chromosomes Cancer 45(10):893–904

  15. Rücker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Fröhling S, Bentz M, Miller S, Scholl C, Schlenk RF, Radlwimmer B, Kestler HA, Pollack JR, Lichter P, Döhner K, Döhner H (2006) Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 24(24):3887–3894

    Article  PubMed  Google Scholar 

  16. Stephens K, Weaver M, Leppig KA, Maruyama K, Emanuel PD, Le Beau MM, Shannon KM (2006) Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood 108(5):1684–1689

    Article  PubMed  CAS  Google Scholar 

  17. Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Nigro LL, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Zwaan CM, van den Heuvel-Eibrink MM (2006) Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 114(12):2489–2496

    Article  Google Scholar 

  18. Staser K, Yang FC, Clapp DW (2010) Mast cells and the neurofibroma microenvironment. Blood 116(2):157–164

    Google Scholar 

  19. Kim SJ, Seo JH, Lee SW, Han E, Lee ES, Cha SH, Seo BK (2003) A case of non-Hodgkin’s lymphoma in a patient with neurofibromatosis type 1. Korean J Intern Med 18(3):202–205

    Google Scholar 

  20. Itoh T, Tamegane T, Ohmae Y, Nakayama S (1998) Malignant lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease). Rinsho Ketsueki 39(9):698–702

    Google Scholar 

  21. Trattner A, David M, Ingber A, Sandbank MJ (1990) Coexistence of late-onset neurofibromatosis and cutaneous T cell lymphoma. Am Acad Dermatol 23(5 Pt 1):932–934

    Google Scholar 

  22. Matsuzaki M, Shimamoto Y, Yokoyama Y, Suga K, Tokioka T, Sueoka E, Ono K, Sano M, Yamaguchi M (1989) von Recklinghausen’s disease associated with malignant lymphoma. Rinsho Ketsueki 30(3):382–386

    Google Scholar 

Download references

Acknowledgments

This report was supported by grant RS18 of the Istituto Superiore di Sanità to GF. We thank Dr. B. Pollo for sharing information on patient histology and Maria Cristina Ibba for helping in genetic analysis.

Author information

Authors and Affiliations

  1. Fondazione I.R.C.C.S. Istituto Neurologico C. Besta, Unit of Molecular Neuro-Oncology, Milan, Italy

    Marica Eoli

  2. Fondazione I.R.C.C.S. Istituto Neurologico Nazionale C. Mondino, Pavia, Italy

    Donata Bianchessi, Anna Luisa Di Stefano, Elena Prodi, Elena Anghileri & Gaetano Finocchiaro

Authors
  1. Marica Eoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donata Bianchessi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Luisa Di Stefano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elena Prodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elena Anghileri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gaetano Finocchiaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marica Eoli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eoli, M., Bianchessi, D., Di Stefano, A.L. et al. Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease). Neurol Sci 33, 1429–1433 (2012). https://doi.org/10.1007/s10072-011-0886-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-011-0886-8

Keywords

Search

Navigation